+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Radiopharmaceutical Theranostics Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Product Type, Radioisotope, Source, Application, Indication, and End User- Product Image
Radiopharmaceutical Theranostics Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Product Type, Radioisotope, Source, Application, Indication, and End User- Product Image
Sale

Radiopharmaceutical Theranostics Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Product Type, Radioisotope, Source, Application, Indication, and End User

  • PDF Icon

    Report

  • 185 Pages
  • March 2023
  • Region: Global
  • The Insight Partners
  • ID: 5780977
UP TO OFF until Jun 30th 2024
Description Jump to:
The radiopharmaceutical theranostics market is expected to reach US$ 3,441.97 million by 2028 from US$ 1,814.58 million in 2022; it is estimated to grow at a CAGR of 11.3% from 2022 to 2028. The rising incidence of cancer and rising application in treatment of cardiovascular disorder are among the key forces bolstering the market. However, regulatory challenges for the approval of radiopharmaceutical theranostics hinder the radiopharmaceutical theranostics market growth.

Radiopharmaceuticals are important in the diagnosis and therapy of cancer; a diagnostic scan with 123I, 124I, or low-activity 131I-iodide is followed by therapy with high-activity 131I-iodide. Similarly, adrenergic tumors such as pheochromocytoma and neuroblastoma can be imaged with 123 I-meta-iodobenzylguanidine and treated with 131 I-metaiodobenzylguanidine. Bone scintigraphy can be used to select patients with painful bone metastases that progressed from prostate cancer. They might benefit from treatment with beta- or alpha-particle-emitting bone-seeking agents, the newest and most successful of which is 223Ra radium chloride. Somatostatin receptor targeting peptides for diagnosing and treating neuroendocrine tumors with agents such as 68Ga-DOTATATE and 177Lu-DOTATATE, respectively, are among the recently established theranostics.

Cancer is one of the leading causes of death worldwide, responsible for almost 10 million deaths in 2020, or almost one in six. The most common types of cancer are breast, lung, colon, rectum, and prostate. According to National Cancer Registry Program Report 2020, in India, male cancer cases were estimated at 679,421 in 2020 and are expected to further increase to about 763,575 in 2025, while female cancer cases were estimated at 712,758 in 2020 and 806,218 in 2025. As people age, they become immunocompromised and often succumb to cancer risks. Poor lifestyles, longer working hours, increasingly stressful lives, smoking, alcohol consumption, contraceptive use, nulliparity, and reduced breastfeeding all contribute to breast cancer incidence.

According to the American Cancer Society’s 2023 report, ~43,720 new cases of thyroid cancer (12,540 in men and 31,180 in women) are recorded in 2023. The report also revealed that 2,120 deaths occurred from thyroid cancer (970 in men and 1,150 in women) in the same year. Radiopharmaceutical theranostics have promising potential in cancer therapy. Theranostics is the combination of therapeutic and diagnostic techniques that utilize a suitable radiopharmaceutical agent. For example, radioiodine has a well-known theranostic application in diagnosing and treating differentiated thyroid cancer. Several radiopharmaceutical theranostic pairs are available for breast cancer applications. These pairs include 43/44Sc/47Sc, 64Cu/67Cu, 83Sr/89Sr, 86Y/90Y, 110In/111In, 124I/131I, 152Tb/161Tb, 152Tb/149Tb, 68Ga/177Lu, and 90Y/177Lu. 123I/131I is a well-known example of theranostic pair that is used in high-quality single-photon emission computerized tomography (SPECT)/CT for pre- and post-therapeutic assessment of thyroid cancer.

Malignant gliomas are deadly tumors with the availability of only a few therapeutic options. 89Zr- and 177Lu-labeled Lumi804-αCD11b is a promising theranostic technique intended for monitoring and reducing tumor-associated myeloid cells (TAMCs) in gliomas and improving immunotherapy outcomes. Further, theranostics are incorporated in radiometals for PET imaging and targeted radiopharmaceutical therapy (TRT). DOTA-octreotate (dotatate) radiolabeled with Lu-177 (177Lu-dotatate: Lutathera) or Ga-68 (68Ga-dotatate: NetSpot) are approved by the Food and Drug Administration (FDA) for targeted radiopharmaceutical therapy (TRT) and positron emission tomography (PET) imaging. Thus, a radiopharmaceutical theranostic approach has unprecedented value in diagnosing and treating different types of cancer, which fuels the overall radiopharmaceutical theranostics market growth.

Product Type Insights

Based on product type, the radiopharmaceutical theranostics market is segmented positron emission tomography (PET) tracers, beta emitters, and alpha emitters. In 2022, the positron emission tomography (PET) tracers segment held the largest market share in radiopharmaceutical theranostics market, and it is anticipated to register the highest CAGR during the forecast period (2022-2028). PET is an imaging technique that provides quantitative information on the distribution of PET radiopharmaceuticals in the body. PET imaging requires expensive equipment, which includes a cyclotron for radionuclide production, automated chemistry devices, purification instrumentation, and PET cameras. PET imaging is used in areas such as cardiology, neurology, and cancer diagnosis. PET may detect the early onset of disease before it is evident on other imaging tests. Better resolution can be achieved via PET using positron emitters, such as gallium-68 and fluorine-18. PET tracers featuring radioactive copper have also been developed as a promising alternative for existing hypoxia imaging techniques due to their high membrane permeability and low redox potential. The success of Ga-PSMA-11 further inspired the development of PSMA-targeting PET tracers for imaging prostate cancer. Additionally, theranostics PET tracers are progressively used in radiopharmaceutical drug development and its application. Theranostic PET tracers have the potential to serve as a noninvasive whole-body navigator, which helps select the most effective drug candidates, and determine optimal dosage and administration route. Thus, benefits such as higher resolution, and quantification of activity boost the radiopharmaceutical theranostics market for the PET tracers segment.

Radioisotope Insights

Based on radioisotope, the radiopharmaceutical theranostics market is segmented Lutetium (Lu) 177, Gallium-68, Iodine-131, Iodine-123, Technetium-99, Yttrium-90 (Y-90), Copper (Cu) 64, 18F, Copper (Cu) 67, and others. In 2022, the Lutetium (Lu) 177 segment held the largest market share in radiopharmaceutical theranostics market, and it is anticipated to register the highest CAGR of 12.3% during the forecast period (2022-2028). Lutetium-177 (177Lu) is the latest addition to the field of nuclear medicine. It has potential to become one of the most extensively used therapeutic radionuclides in the coming years. Lu-177 PSMA therapy for cancer theranostic is employed to treat advanced prostate cancer cases. Lu-177 octreotate therapy is used to treat neuroendocrine tumors (NETs), including head and neck cancers and gastrointestinal tumors. Lutetium therapy (lutetium-177-DOTA-oxodotreotide) has been identified as targeted radionuclide therapy or peptide receptor radionuclide therapy (PRRT). The US Food and Drug Administration (FDA) has approved 177Lu-labeled DOTA-TATE for peptide receptor radionuclide therapy (PRRT).

Source Insights

Based on source, the radiopharmaceutical theranostics market is divided into cyclotrons and nuclear reactors. In 2022, the cyclotrons segment held a larger market share in radiopharmaceutical theranostics market and is anticipated to register a higher CAGR during the forecast period (2022-2028). Cyclotrons are best suited for producing proton-rich radioisotopes such as Fluorine-18 (18F). Commercially available cyclotron-produced medical radioisotope involves Carbon-11, Nitrogen-13, Oxygen-15, Fluorine-18 (18F), Copper-64, Gallium-67, Iodine-123, and Thallium-201. According to the International Atomic Energy Agency (IAEA) 2023 report, the most frequent radioisotope produced through cyclotrons are those with short half-lives, particularly fluorine-18, carbon-11, oxygen-15, and nitrogen-13, intended for imaging techniques such as positron emission tomography (PET). Cyclotrons account for almost 95% of the production of radiopharmaceuticals used in PET. Additionally, the demand for cyclotrons is increasing as radionuclides are majorly used in research, diagnosis, and treatment of a range of life-threatening diseases such as cancer, Parkinson's, Alzheimer's, and insomnia. Further, medical imaging techniques such as PET and SPECT depend on cyclotron-produced radioisotopes.

Application Insights

Based on application, the radiopharmaceutical theranostics market is bifurcated into targeted therapeutic (Rx) and companion diagnostic (CDx). The targeted therapeutic (Rx) segment held a larger market share in radiopharmaceutical theranostics market in 2022, and it is expected to register a higher CAGR during the forecast period. Targeted therapeutics have emerged as a promising strategy for treating harmful clinical conditions, such as cancer. For example, "radionuclide," a type of radiation therapy, uses a cell-targeting molecule such as a monoclonal antibody injected into the body. Further, the cell-targeting molecule binds to a specific target molecule on cancer cells, subsequently killing the targeted cancer cells; the mechanism ensures minimum harm to normal cells. Targeted therapeutics are used for treating prostate cancer and other types of cancers. This is well understood by the following case of targeting somatostatin receptors in neuroendocrine pancreatic tumors.

68Ga has been developed for somatostatin receptor imaging such as DOTATOC, DOTATATE, and DOTANOC. A somatostatin-receptor targeted therapy can be utilized for neoadjuvant therapy that renders inoperable pNET resectable by utilizing 177Lu-DOTATATE (27) and 90Y-DOTATATE (28). 90Y is a beta-emitting radionuclide best suited for bulky pancreatic tumors. Additionally, 177Lu-DOTATOC and 213Bi-DOTATOC have revealed relatively high biological effectiveness, and they are effectively responsible for decreasing the survival of pancreatic adenocarcinoma cells.

Indication Insights

Based on indication, the radiopharmaceutical theranostics market is segmented oncology, neurology, cardiology, and others. The oncology segment held the largest market share in radiopharmaceutical theranostics market in 2022, and it is anticipated to register the highest CAGR during the forecast period (2022-2028). Theranostics methods involve administering nanoparticles into the patient’s body and using photodynamic therapy, which paves the way for personalized medicine. These methods can be applied in the treatment of esophageal cancer, prostate cancer, and breast cancer, in the treatment of actinic keratosis, actinic cheilitis, Bowen's disease, basal cell epithelioma, and macular degeneration. Therapeutic radiopharmaceuticals for cancer treatment are predominantly labeled with beta-emitting radionuclides. The radionuclides I-131, Lu-177, and Yttrium-90 (Y-90) are frequently used for this purpose. Upon decay, the emitted beta-particles travel 1-12 mm through tissue while losing energy and causing cytotoxic damage to the cell to induce apoptosis. Alternatively, and more recently, alpha-emitting radionuclides, e.g., At-211 or Ac-225, have been explored for therapeutic applications. Theranostics has been successfully used by clinicians and patients in treating prostate cancer. Thus, the strong clinical need for these therapies and targeted treatments in oncology continue to fuel the market for the oncology segment during the forecast period.

End User Insights

Based on end user, the radiopharmaceutical theranostics market is segmented hospitals, diagnostic imaging centers, academic and research institutes, and others. The hospitals segment held the largest market share in 2022 of global radiopharmaceutical theranostics market. However, academic and research institutes segment is anticipated to register the highest CAGR during the forecast period (2022-2028). Hospitals employ technologically advanced systems to treat cardiac aneurysms, neurology aneurysms, oncology tumors, and other similar conditions. The rising prevalence of various diseases and an increasing number of hospitals contribute to the growth of the radiopharmaceutical theranostics market for hospitals segment.

Table of Contents

1. Introduction
1.1 Scope of the Study
1.2 Research Report Guidance
1.3 Market Segmentation
1.3.1 Global Radiopharmaceutical Theranostics Market - by Product Type
1.3.2 Global Radiopharmaceutical Theranostics Market - by Radioisotope
1.3.3 Global Radiopharmaceutical Theranostics Market - by Source
1.3.4 Global Radiopharmaceutical Theranostics Market - by Application
1.3.5 Global Radiopharmaceutical Theranostics Market - by Indication
1.3.6 Global Radiopharmaceutical Theranostics Market - by End User
1.3.7 Global Radiopharmaceutical Theranostics Market - by Geography
2. Radiopharmaceutical Theranostics Market - Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Radiopharmaceutical Theranostics Market - Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 North America PEST Analysis
4.2.2 Europe PEST Analysis
4.2.3 Asia Pacific PEST Analysis
4.2.4 South & Central America PEST Analysis
4.2.5 Middle East & Africa PEST Analysis
4.3 Expert’s Opinion
5. Radiopharmaceutical Theranostics Market - Key Market Dynamics
5.1 Market Drivers
5.1.1 Rising Incidence of Cancer
5.1.2 Rising Application in Treatment of Cardiovascular Disorders
5.2 Market Restraints
5.2.1 Regulatory Challenges for Approval of Radiopharmaceutical Theranostics
5.3 Market Opportunities
5.3.1 Theranostic Digital Twins for Personalized Radiopharmaceutical Therapies
5.4 Future Trends
5.4.1 Radiopharmaceutical Theranostics in Nuclear Medicine
5.5 Impact Analysis
6. Radiopharmaceutical Theranostics Market - Global Analysis
6.1 Global Radiopharmaceutical Theranostics Market Revenue Forecast and Analysis
6.2 Global Radiopharmaceutical Theranostics Market, by Geography - Forecast and Analysis
6.3 Market Positioning of Key Players
6.3.1 GE HealthCare Technologies Inc
6.3.2 Curium
7. Global Radiopharmaceutical Theranostics Market - Revenue and Forecast to 2028 - by Product Type
7.1 Overview
7.2 Global Radiopharmaceutical Theranostics Market Revenue Share, by Product Type 2021 & 2028 (%)
7.2.1 Positron Emission Tomography (PET) Tracers
7.2.1.1 Overview
7.2.1.2 Positron Emission Tomography (PET) Tracers: Global Radiopharmaceutical Theranostics Market - Revenue and Forecast to 2028 (US$ Million)
7.2.2 Beta Emitters
7.2.2.1 Overview
7.2.2.2 Beta Emitters: Global Radiopharmaceutical Theranostics Market - Revenue and Forecast to 2028 (US$ Million)
7.2.3 Alpha Emitters
7.2.3.1 Overview
7.2.3.2 Alpha Emitters: Global Radiopharmaceutical Theranostics Market - Revenue and Forecast to 2028 (US$ Million)
8. Global Radiopharmaceutical Theranostics Market Analysis - by Radioisotope
8.1 Overview
8.2 Global Radiopharmaceutical Theranostics Market Revenue Share, by Radioisotope 2021 & 2028 (%)
8.2.1 Technetium-
8.2.1.1 Overview
8.2.1.2 Technetium-99: Global Radiopharmaceutical Theranostics Market - Revenue and Forecast to 2028 (US$ Million)
8.2.2 Gallium-
8.2.2.1 Overview
8.2.2.2 Gallium-68: Global Radiopharmaceutical Theranostics Market - Revenue and Forecast to 2028 (US$ Million)
8.2.3 Iodine-
8.2.3.1 Overview
8.2.3.2 Iodine-131: Global Radiopharmaceutical Theranostics Market - Revenue and Forecast to 2028 (US$ Million)
8.2.4 Iodine-
8.2.4.1 Overview
8.2.4.2 Iodine-123: Global Radiopharmaceutical Theranostics Market - Revenue and Forecast to 2028 (US$ Million)
8.2.5 Fluorine-18 (18F)
8.2.5.1 Overview
8.2.5.2 Fluorine-18 (18F): Global Radiopharmaceutical Theranostics Market - Revenue and Forecast to 2028 (US$ Million)
8.2.6 Yttrium 90 (Y-90)
8.2.6.1 Overview
8.2.6.2 Yttrium 90 (Y-90): Global Radiopharmaceutical Theranostics Market - Revenue and Forecast to 2028 (US$ Million)
8.2.7 Lutetium (LU)
8.2.7.1 Overview
8.2.7.2 Lutetium (LU) 177: Global Radiopharmaceutical Theranostics Market - Revenue and Forecast to 2028 (US$ Million)
8.2.8 Copper (CU)
8.2.8.1 Overview
8.2.8.2 Copper (CU) 67: Global Radiopharmaceutical Theranostics Market - Revenue and Forecast to 2028 (US$ Million)
8.2.9 Copper (CU)
8.2.9.1 Overview
8.2.9.2 Copper (CU) 64: Global Radiopharmaceutical Theranostics Market - Revenue and Forecast to 2028 (US$ Million)
8.2.10 Others
8.2.10.1 Overview
8.2.10.2 Others: Global Radiopharmaceutical Theranostics Market - Revenue and Forecast to 2028 (US$ Million)
9. Global Radiopharmaceutical Theranostics Market Analysis - by Source
9.1 Overview
9.2 Global Radiopharmaceutical Theranostics Market Revenue Share, by Source 2021 & 2028 (%)
9.2.1 Nuclear Reactors
9.2.1.1 Overview
9.2.1.2 Nuclear Reactors: Global Radiopharmaceutical Theranostics Market - Revenue and Forecast to 2028 (US$ Million)
9.2.2 Cyclotrons
9.2.2.1 Overview
9.2.2.2 Cyclotrons: Global Radiopharmaceutical Theranostics Market - Revenue and Forecast to 2028 (US$ Million)
10. Global Radiopharmaceutical Theranostics Market Analysis - by Application
10.1 Overview
10.2 Global Radiopharmaceutical Theranostics Market Revenue Share, by Application 2021 & 2028 (%)
10.2.1 Targeted Therapeutic (Rx)
10.2.1.1 Overview
10.2.1.2 Targeted Therapeutics (Rx): Global Radiopharmaceutical Theranostics Market - Revenue and Forecast to 2028 (US$ Million)
10.2.2 Companion Diagnostic (CDx)
10.2.2.1 Overview
10.2.2.2 Companion Diagnostics (CDx): Global Radiopharmaceutical Theranostics Market - Revenue and Forecast to 2028 (US$ Million)
11. Global Radiopharmaceutical Theranostics Market Analysis - by Indication
11.1 Overview
11.2 Global Radiopharmaceutical Theranostics Market Revenue Share, by Indication 2021 & 2028 (%)
11.2.1 Oncology
11.2.1.1 Overview
11.2.1.2 Oncology: Global Radiopharmaceutical Theranostics Market - Revenue and Forecast to 2028 (US$ Million)
11.2.2 Neurology
11.2.2.1 Overview
11.2.2.2 Neurology: Global Radiopharmaceutical Theranostics Market - Revenue and Forecast to 2028 (US$ Million)
11.2.3 Cardiology
11.2.3.1 Overview
11.2.3.2 Cardiology: Global Radiopharmaceutical Theranostics Market - Revenue and Forecast to 2028 (US$ Million)
11.2.4 Others
11.2.4.1 Overview
11.2.4.2 Others: Global Radiopharmaceutical Theranostics Market - Revenue and Forecast to 2028 (US$ Million)
12. Global Radiopharmaceutical Theranostics Market Analysis - by End User
12.1 Overview
12.2 Global Radiopharmaceutical Theranostics Market Revenue Share, by End User 2021 & 2028 (%)
12.2.1 Hospitals
12.2.1.1 Overview
12.2.1.2 Hospitals: Global Radiopharmaceutical Theranostics Market - Revenue and Forecast to 2028 (US$ Million)
12.2.2 Diagnostic Imaging Centers
12.2.2.1 Overview
12.2.2.2 Diagnostic Imaging Centers: Global Radiopharmaceutical Theranostics Market - Revenue and Forecast to 2028 (US$ Million)
12.2.3 Academic & Research Institutes
12.2.3.1 Overview
12.2.3.2 Academic & Research Institutes: Global Radiopharmaceutical Theranostics Market - Revenue and Forecast to 2028 (US$ Million)
12.2.4 Others
12.2.4.1 Overview
12.2.4.2 Others: Global Radiopharmaceutical Theranostics Market - Revenue and Forecast to 2028 (US$ Million)
13. Radiopharmaceutical Theranostics Market - Revenue and Forecast to 2028 - Geographic Analysis
13.1 North America: Radiopharmaceutical Theranostics Market
13.1.1 Overview
13.1.2 North America: Radiopharmaceutical Theranostics Market - Revenue and Forecast to 2028 (US$ Million)
13.1.3 North America: Radiopharmaceutical Theranostics Market, by Product Type, 2019-2028 (US$ Million)
13.1.4 North America: Radiopharmaceutical Theranostics Market, by Radioisotope, 2019-2028 (US$ Million)
13.1.5 North America: Radiopharmaceutical Theranostics Market, by Source, 2019-2028 (US$ Million)
13.1.6 North America: Radiopharmaceutical Theranostics Market, by Application, 2019-2028 (US$ Million)
13.1.7 North America: Radiopharmaceutical Theranostics Market, by Indication, 2019-2028 (US$ Million)
13.1.8 North America: Radiopharmaceutical Theranostics Market, by End User, 2019-2028 (US$ Million)
13.1.8.1 United States: Radiopharmaceutical Theranostics Market - Revenue and Forecast to 2028 (US$ Million)
13.1.8.1.1 Overview
13.1.8.1.2 United States: Radiopharmaceutical Theranostics Market - Revenue and Forecast to 2028 (US$ Million)
13.1.8.1.3 United States Radiopharmaceutical Theranostics Market, by Product Type, 2019-2028 (US$ Million)
13.1.8.1.4 United States Radiopharmaceutical Theranostics Market, by Radioisotope, 2019-2028 (US$ Million)
13.1.8.1.5 United States Radiopharmaceutical Theranostics Market, by Source, 2019-2028 (US$ Million)
13.1.8.1.6 United States Radiopharmaceutical Theranostics Market, by Application, 2019-2028 (US$ Million)
13.1.8.1.7 United States Radiopharmaceutical Theranostics Market, by Indication, 2019-2028 (US$ Million)
13.1.8.1.8 United States Radiopharmaceutical Theranostics Market, by End User, 2019-2028 (US$ Million)
13.1.8.2 Canada: Radiopharmaceutical Theranostics Market - Revenue and Forecast to 2028 (US$ Million)
13.1.8.2.1 Overview
13.1.8.2.2 Canada: Radiopharmaceutical Theranostics Market - Revenue and Forecast to 2028 (US$ Million)
13.1.8.2.3 Canada Radiopharmaceutical Theranostics Market, by Product Type, 2019-2028 (US$ Million)
13.1.8.2.4 Canada Radiopharmaceutical Theranostics Market, by Radioisotope, 2019-2028 (US$ Million)
13.1.8.2.5 Canada Radiopharmaceutical Theranostics Market, by Source, 2019-2028 (US$ Million)
13.1.8.2.6 Canada Radiopharmaceutical Theranostics Market, by Application, 2019-2028 (US$ Million)
13.1.8.2.7 Canada Radiopharmaceutical Theranostics Market, by Indication, 2019-2028 (US$ Million)
13.1.8.2.8 Canada Radiopharmaceutical Theranostics Market, by End User, 2019-2028 (US$ Million)
13.1.8.3 Mexico: Radiopharmaceutical Theranostics Market - Revenue and Forecast to 2028 (US$ Million)
13.1.8.3.1 Overview
13.1.8.3.2 Mexico: Radiopharmaceutical Theranostics Market - Revenue and Forecast to 2028 (US$ Million)
13.1.8.3.3 Mexico Radiopharmaceutical Theranostics Market, by Product Type, 2019-2028 (US$ Million)
13.1.8.3.4 Mexico Radiopharmaceutical Theranostics Market, by Radioisotope, 2019-2028 (US$ Million)
13.1.8.3.5 Mexico Radiopharmaceutical Theranostics Market, by Source, 2019-2028 (US$ Million)
13.1.8.3.6 Mexico Radiopharmaceutical Theranostics Market, by Application, 2019-2028 (US$ Million)
13.1.8.3.7 Mexico Radiopharmaceutical Theranostics Market, by Indication, 2019-2028 (US$ Million)
13.1.8.3.8 Mexico Radiopharmaceutical Theranostics Market, by End User, 2019-2028 (US$ Million)
13.2 Europe: Radiopharmaceutical Theranostics Market
13.2.1 Overview
13.2.2 Europe: Radiopharmaceutical Theranostics Market - Revenue and Forecast to 2028 (US$ Million)
13.2.3 Europe: Radiopharmaceutical Theranostics Market, by Product Type, 2019-2028 (US$ Million)
13.2.4 Europe: Radiopharmaceutical Theranostics Market, by Radioisotope, 2019-2028 (US$ Million)
13.2.5 Europe: Radiopharmaceutical Theranostics Market, by Source, 2019-2028 (US$ Million)
13.2.6 Europe: Radiopharmaceutical Theranostics Market, by Application, 2019-2028 (US$ Million)
13.2.7 Europe: Radiopharmaceutical Theranostics Market, by Indication, 2019-2028 (US$ Million)
13.2.8 Europe: Radiopharmaceutical Theranostics Market, by End User, 2019-2028 (US$ Million)
13.2.9 Europe: Radiopharmaceutical Theranostics Market, by Country, 2021 & 2028 (%)
13.2.9.1 Germany: Radiopharmaceutical Theranostics Market - Revenue and Forecast to 2028 (US$ Million)
13.2.9.1.1 Overview
13.2.9.1.2 Germany Radiopharmaceutical Theranostics Market - Revenue and Forecast to 2028 (US$ Million)
13.2.9.1.3 Germany Radiopharmaceutical Theranostics Market, by Product Type, 2019-2028 (US$ Million)
13.2.9.1.4 Germany Radiopharmaceutical Theranostics Market, by Radioisotope, 2019-2028 (US$ Million)
13.2.9.1.5 Germany Radiopharmaceutical Theranostics Market, by Source, 2019-2028 (US$ Million)
13.2.9.1.6 Germany Radiopharmaceutical Theranostics Market, by Application, 2019-2028 (US$ Million)
13.2.9.1.7 Germany Radiopharmaceutical Theranostics Market, by Indication, 2019-2028 (US$ Million)
13.2.9.1.8 Germany Radiopharmaceutical Theranostics Market, by End User, 2019-2028 (US$ Million)
13.2.9.2 United Kingdom: Radiopharmaceutical Theranostics Market - Revenue and Forecast to 2028 (US$ Million)
13.2.9.2.1 Overview
13.2.9.2.2 United Kingdom Radiopharmaceutical Theranostics Market - Revenue and Forecast to 2028 (US$ Million)
13.2.9.2.3 United Kingdom Radiopharmaceutical Theranostics Market, by Product type, 2019-2028 (US$ Million)
13.2.9.2.4 United Kingdom Radiopharmaceutical Theranostics Market, by Radioisotope, 2019-2028 (US$ Million)
13.2.9.2.5 United Kingdom Radiopharmaceutical Theranostics Market, by Source, 2019-2028 (US$ Million)
13.2.9.2.6 United Kingdom Radiopharmaceutical Theranostics Market, by Application, 2019-2028 (US$ Million)
13.2.9.2.7 United Kingdom Radiopharmaceutical Theranostics Market, by Indication, 2019-2028 (US$ Million)
13.2.9.2.8 United Kingdom Radiopharmaceutical Theranostics Market, by End User, 2019-2028 (US$ Million)
13.2.9.3 France: Radiopharmaceutical Theranostics Market - Revenue and Forecast to 2028 (US$ Million)
13.2.9.3.1 Overview
13.2.9.3.2 France Radiopharmaceutical Theranostics Market - Revenue and Forecast to 2028 (US$ Million)
13.2.9.3.3 France Radiopharmaceutical Theranostics Market, by Product Type, 2019-2028 (US$ Million)
13.2.9.3.4 France Radiopharmaceutical Theranostics Market, by Radioisotope, 2019-2028 (US$ Million)
13.2.9.3.5 France Radiopharmaceutical Theranostics Market, by Source, 2019-2028 (US$ Million)
13.2.9.3.6 France Radiopharmaceutical Theranostics Market, by Application, 2019-2028 (US$ Million)
13.2.9.3.7 France Radiopharmaceutical Theranostics Market, by Indication, 2019-2028 (US$ Million)
13.2.9.3.8 France Radiopharmaceutical Theranostics Market, by End User, 2019-2028 (US$ Million)
13.2.9.4 Italy: Radiopharmaceutical Theranostics Market - Revenue and Forecast to 2028 (US$ Million)
13.2.9.4.1 Overview
13.2.9.4.2 Italy Radiopharmaceutical Theranostics Market - Revenue and Forecast to 2028 (US$ Million)
13.2.9.4.3 Italy Radiopharmaceutical Theranostics Market, by Product Type, 2019-2028 (US$ Million)
13.2.9.4.4 Italy Radiopharmaceutical Theranostics Market, by Radioisotope, 2019-2028 (US$ Million)
13.2.9.4.5 Italy Radiopharmaceutical Theranostics Market, by Source, 2019-2028 (US$ Million)
13.2.9.4.6 Italy Radiopharmaceutical Theranostics Market, by Application, 2019-2028 (US$ Million)
13.2.9.4.7 Italy Radiopharmaceutical Theranostics Market, by Indication, 2019-2028 (US$ Million)
13.2.9.4.8 Italy Radiopharmaceutical Theranostics Market, by End User, 2019-2028 (US$ Million)
13.2.9.5 Spain: Radiopharmaceutical Theranostics Market - Revenue and Forecast to 2028 (US$ Million)
13.2.9.5.1 Overview
13.2.9.5.2 Spain Radiopharmaceutical Theranostics Market - Revenue and Forecast to 2028 (US$ Million)
13.2.9.5.3 Spain Radiopharmaceutical Theranostics Market, by Product Type, 2019-2028 (US$ Million)
13.2.9.5.4 Spain Radiopharmaceutical Theranostics Market, by Radioisotope, 2019-2028 (US$ Million)
13.2.9.5.5 Spain Radiopharmaceutical Theranostics Market, by Source, 2019-2028 (US$ Million)
13.2.9.5.6 Spain Radiopharmaceutical Theranostics Market, by Application, 2019-2028 (US$ Million)
13.2.9.5.7 Spain Radiopharmaceutical Theranostics Market, by Indication, 2019-2028 (US$ Million)
13.2.9.5.8 Spain Radiopharmaceutical Theranostics Market, by End User, 2019-2028 (US$ Million)
13.2.9.6 Rest of Europe: Radiopharmaceutical Theranostics Market - Revenue and Forecast to 2028 (US$ Million)
13.2.9.6.1 Overview
13.2.9.6.2 Rest of Europe Radiopharmaceutical Theranostics Market - Revenue and Forecast to 2028 (US$ Million)
13.2.9.6.3 Rest of Europe Radiopharmaceutical Theranostics Market, by Product Type, 2019-2028 (US$ Million)
13.2.9.6.4 Rest of Europe Radiopharmaceutical Theranostics Market, by Radioisotope, 2019-2028 (US$ Million)
13.2.9.6.5 Rest of Europe Radiopharmaceutical Theranostics Market, by Source, 2019-2028 (US$ Million)
13.2.9.6.6 Rest of Europe Radiopharmaceutical Theranostics Market, by Application, 2019-2028 (US$ Million)
13.2.9.6.7 Rest of Europe Radiopharmaceutical Theranostics Market, by Indication, 2019-2028 (US$ Million)
13.2.9.6.8 Rest of Europe Radiopharmaceutical Theranostics Market, by End User, 2019-2028 (US$ Million)
13.3 Asia Pacific: Radiopharmaceutical Theranostics Market
13.3.1 Overview
13.3.2 Asia Pacific: Radiopharmaceutical Theranostics Market - Revenue and Forecast to 2028 (US$ Million)
13.3.3 Asia Pacific: Radiopharmaceutical Theranostics Market, by Product Type, 2019-2028 (US$ Million)
13.3.4 Asia Pacific: Radiopharmaceutical Theranostics Market, by Radioisotope, 2019-2028 (US$ Million)
13.3.5 Asia Pacific: Radiopharmaceutical Theranostics Market, by Source, 2019-2028 (US$ Million)
13.3.6 Asia Pacific: Radiopharmaceutical Theranostics Market, by Application, 2019-2028 (US$ Million)
13.3.7 Asia Pacific: Radiopharmaceutical Theranostics Market, by Indication, 2019-2028 (US$ Million)
13.3.8 Asia Pacific: Radiopharmaceutical Theranostics Market, by End User, 2019-2028 (US$ Million)
13.3.9 Asia Pacific: Radiopharmaceutical Theranostics Market, by Country, 2021 & 2028 (%)
13.3.9.1 China: Radiopharmaceutical Theranostics Market - Revenue and Forecast to 2028 (US$ Million)
13.3.9.1.1 Overview
13.3.9.1.2 China: Radiopharmaceutical Theranostics Market - Revenue and Forecast to 2028 (US$ Million)
13.3.9.1.3 China Radiopharmaceutical Theranostics Market, by Product Type, 2019-2028 (US$ Million)
13.3.9.1.4 China Radiopharmaceutical Theranostics Market, by Radioisotope, 2019-2028 (US$ Million)
13.3.9.1.5 China Radiopharmaceutical Theranostics Market, by Source, 2019-2028 (US$ Million)
13.3.9.1.6 China Radiopharmaceutical Theranostics Market, by Application, 2019-2028 (US$ Million)
13.3.9.1.7 China Radiopharmaceutical Theranostics Market, by Indication, 2019-2028 (US$ Million)
13.3.9.1.8 China Radiopharmaceutical Theranostics Market, by End User, 2019-2028 (US$ Million)
13.3.9.2 Japan: Radiopharmaceutical Theranostics Market - Revenue and Forecast to 2028 (US$ Million)
13.3.9.2.1 Overview
13.3.9.2.2 Japan: Radiopharmaceutical Theranostics Market - Revenue and Forecast to 2028 (US$ Million)
13.3.9.2.3 Japan Radiopharmaceutical Theranostics Market, by Product Type, 2019-2028 (US$ Million)
13.3.9.2.4 Japan Radiopharmaceutical Theranostics Market, by Radioisotope, 2019-2028 (US$ Million)
13.3.9.2.5 Japan Radiopharmaceutical Theranostics Market, by Source, 2019-2028 (US$ Million)
13.3.9.2.6 Japan Radiopharmaceutical Theranostics Market, by Application, 2019-2028 (US$ Million)
13.3.9.2.7 Japan Radiopharmaceutical Theranostics Market, by Indication, 2019-2028 (US$ Million)
13.3.9.2.8 Japan Radiopharmaceutical Theranostics Market, by End User, 2019-2028 (US$ Million)
13.3.9.3 India: Radiopharmaceutical Theranostics Market - Revenue and Forecast to 2028 (US$ Million)
13.3.9.3.1 Overview
13.3.9.3.2 India: Radiopharmaceutical Theranostics Market - Revenue and Forecast to 2028 (US$ Million)
13.3.9.3.3 India Radiopharmaceutical Theranostics Market, by Product Type, 2019-2028 (US$ Million)
13.3.9.3.4 India Radiopharmaceutical Theranostics Market, by Radioisotope, 2019-2028 (US$ Million)
13.3.9.3.5 India Radiopharmaceutical Theranostics Market, by Source, 2019-2028 (US$ Million)
13.3.9.3.6 India Radiopharmaceutical Theranostics Market, by Application, 2019-2028 (US$ Million)
13.3.9.3.7 India Radiopharmaceutical Theranostics Market, by Indication, 2019-2028 (US$ Million)
13.3.9.3.8 India Radiopharmaceutical Theranostics Market, by End User, 2019-2028 (US$ Million)
13.3.9.4 South Korea: Radiopharmaceutical Theranostics Market - Revenue and Forecast to 2028 (US$ Million)
13.3.9.4.1 Overview
13.3.9.4.2 South Korea: Radiopharmaceutical Theranostics Market - Revenue and Forecast to 2028 (US$ Million)
13.3.9.4.3 South Korea Radiopharmaceutical Theranostics Market, by Product Type, 2019-2028 (US$ Million)
13.3.9.4.4 South Korea Radiopharmaceutical Theranostics Market, by Radioisotope, 2019-2028 (US$ Million)
13.3.9.4.5 South Korea Radiopharmaceutical Theranostics Market, by Source, 2019-2028 (US$ Million)
13.3.9.4.6 South Korea Radiopharmaceutical Theranostics Market, by Application, 2019-2028 (US$ Million)
13.3.9.4.7 South Korea Radiopharmaceutical Theranostics Market, by Indication, 2019-2028 (US$ Million)
13.3.9.4.8 South Korea Radiopharmaceutical Theranostics Market, by End User, 2019-2028 (US$ Million)
13.3.9.5 Australia: Radiopharmaceutical Theranostics Market - Revenue and Forecast to 2028 (US$ Million)
13.3.9.5.1 Overview
13.3.9.5.2 Australia: Radiopharmaceutical Theranostics Market - Revenue and Forecast to 2028 (US$ Million)
13.3.9.5.3 Australia Radiopharmaceutical Theranostics Market, by Product Type, 2019-2028 (US$ Million)
13.3.9.5.4 Australia Radiopharmaceutical Theranostics Market, by Radioisotope, 2019-2028 (US$ Million)
13.3.9.5.5 Australia Radiopharmaceutical Theranostics Market, by Source, 2019-2028 (US$ Million)
13.3.9.5.6 Australia Radiopharmaceutical Theranostics Market, by Application, 2019-2028 (US$ Million)
13.3.9.5.7 Australia Radiopharmaceutical Theranostics Market, by Indication, 2019-2028 (US$ Million)
13.3.9.5.8 Australia Radiopharmaceutical Theranostics Market, by End User, 2019-2028 (US$ Million)
13.3.9.6 Rest of Asia Pacific: Radiopharmaceutical Theranostics Market - Revenue and Forecast to 2028 (US$ Million)
13.3.9.6.1 Overview
13.3.9.6.2 Rest of Asia Pacific: Radiopharmaceutical Theranostics Market - Revenue and Forecast to 2028 (US$ Million)
13.3.9.6.3 Rest of Asia Pacific Radiopharmaceutical Theranostics Market, by Product Type, 2019-2028 (US$ Million)
13.3.9.6.4 Rest of Asia Pacific Radiopharmaceutical Theranostics Market, by Radioisotope, 2019-2028 (US$ Million)
13.3.9.6.5 Rest of Asia Pacific Radiopharmaceutical Theranostics Market, by Source, 2019-2028 (US$ Million)
13.3.9.6.6 Rest of Asia Pacific Radiopharmaceutical Theranostics Market, by Application, 2019-2028 (US$ Million)
13.3.9.6.7 Rest of Asia Pacific Radiopharmaceutical Theranostics Market, by Indication, 2019-2028 (US$ Million)
13.3.9.6.8 Rest of Asia Pacific Radiopharmaceutical Theranostics Market, by End User, 2019-2028 (US$ Million)
13.4 Middle East & Africa Radiopharmaceutical Theranostics Market
13.4.1 Overview
13.4.2 Middle East & Africa: Radiopharmaceutical Theranostics Market - Revenue and Forecast to 2028 (US$ Million)
13.4.3 Middle East & Africa: Radiopharmaceutical Theranostics Market, by Product Type, 2019-2028 (US$ Million)
13.4.4 Middle East & Africa: Radiopharmaceutical Theranostics Market, by Radioisotope, 2019-2028 (US$ Million)
13.4.5 Middle East & Africa: Radiopharmaceutical Theranostics Market, by Source, 2019-2028 (US$ Million)
13.4.6 Middle East & Africa: Radiopharmaceutical Theranostics Market, by Application, 2019-2028 (US$ Million)
13.4.7 Middle East & Africa: Radiopharmaceutical Theranostics Market, by Indication, 2019-2028 (US$ Million)
13.4.8 Middle East & Africa: Radiopharmaceutical Theranostics Market, by End User, 2019-2028 (US$ Million)
13.4.9 Middle East & Africa: Radiopharmaceutical Theranostics Market, by Country, 2021 & 2028 (%)
13.4.9.1 Saudi Arabia: Radiopharmaceutical Theranostics Market - Revenue and Forecast to 2028 (US$ Million)
13.4.9.1.1 Overview
13.4.9.1.2 Saudi Arabia Radiopharmaceutical Theranostics Market - Revenue and Forecast to 2028 (US$ Million)
13.4.9.1.3 Saudi Arabia Radiopharmaceutical Theranostics Market, by Product Type, 2019-2028 (US$ Million)
13.4.9.1.4 Saudi Arabia Radiopharmaceutical Theranostics Market, by Radioisotope, 2019-2028 (US$ Million)
13.4.9.1.5 Saudi Arabia Radiopharmaceutical Theranostics Market, by Source, 2019-2028 (US$ Million)
13.4.9.1.6 Saudi Arabia Radiopharmaceutical Theranostics Market, by Application, 2019-2028 (US$ Million)
13.4.9.1.7 Saudi Arabia Radiopharmaceutical Theranostics Market, by Indication, 2019-2028 (US$ Million)
13.4.9.1.8 Saudi Arabia Radiopharmaceutical Theranostics Market, by End User, 2019-2028 (US$ Million)
13.4.9.2 South Africa: Radiopharmaceutical Theranostics Market - Revenue and Forecast to 2028 (US$ Million)
13.4.9.2.1 Overview
13.4.9.2.2 South Africa Radiopharmaceutical Theranostics Market - Revenue and Forecast to 2028 (US$ Million)
13.4.9.2.3 South Africa Radiopharmaceutical Theranostics Market, by Product type, 2019-2028 (US$ Million)
13.4.9.2.4 South Africa Radiopharmaceutical Theranostics Market, by Radioisotope, 2019-2028 (US$ Million)
13.4.9.2.5 South Africa Radiopharmaceutical Theranostics Market, by Source, 2019-2028 (US$ Million)
13.4.9.2.6 South Africa Radiopharmaceutical Theranostics Market, by Application, 2019-2028 (US$ Million)
13.4.9.2.7 South Africa Radiopharmaceutical Theranostics Market, by Indication, 2019-2028 (US$ Million)
13.4.9.2.8 South Africa Radiopharmaceutical Theranostics Market, by End User, 2019-2028 (US$ Million)
13.4.9.3 UAE: Radiopharmaceutical Theranostics Market - Revenue and Forecast to 2028 (US$ Million)
13.4.9.3.1 Overview
13.4.9.3.2 UAE Radiopharmaceutical Theranostics Market - Revenue and Forecast to 2028 (US$ Million)
13.4.9.3.3 UAE Radiopharmaceutical Theranostics Market, by Product Type, 2019-2028 (US$ Million)
13.4.9.3.4 UAE Radiopharmaceutical Theranostics Market, by Radioisotope, 2019-2028 (US$ Million)
13.4.9.3.5 UAE Radiopharmaceutical Theranostics Market, by Source, 2019-2028 (US$ Million)
13.4.9.3.6 UAE Radiopharmaceutical Theranostics Market, by Application, 2019-2028 (US$ Million)
13.4.9.3.7 UAE Radiopharmaceutical Theranostics Market, by Indication, 2019-2028 (US$ Million)
13.4.9.3.8 UAE Radiopharmaceutical Theranostics Market, by End User, 2019-2028 (US$ Million)
13.4.9.4 Rest of Middle East & Africa: Radiopharmaceutical Theranostics Market - Revenue and Forecast to 2028 (US$ Million)
13.4.9.4.1 Overview
13.4.9.4.2 Rest of Middle East & Africa Radiopharmaceutical Theranostics Market - Revenue and Forecast to 2028 (US$ Million)
13.4.9.4.3 Rest of Middle East & Africa Radiopharmaceutical Theranostics Market, by Product Type, 2019-2028 (US$ Million)
13.4.9.4.4 Rest of Middle East & Africa Radiopharmaceutical Theranostics Market, by Radioisotope, 2019-2028 (US$ Million)
13.4.9.4.5 Rest of Middle East & Africa Radiopharmaceutical Theranostics Market, by Source, 2019-2028 (US$ Million)
13.4.9.4.6 Rest of Middle East & Africa Radiopharmaceutical Theranostics Market, by Application, 2019-2028 (US$ Million)
13.4.9.4.7 Rest of Middle East & Africa Radiopharmaceutical Theranostics Market, by Indication, 2019-2028 (US$ Million)
13.4.9.4.8 Rest of Middle East & Africa Radiopharmaceutical Theranostics Market, by End User, 2019-2028 (US$ Million)
13.5 South & Central America Radiopharmaceutical Theranostics Market
13.5.1 Overview
13.5.2 South & Central America: Radiopharmaceutical Theranostics Market - Revenue and Forecast to 2028 (US$ Million)
13.5.3 South & Central America: Radiopharmaceutical Theranostics Market, by Product Type, 2019-2028 (US$ Million)
13.5.4 South & Central America: Radiopharmaceutical Theranostics Market, by Radioisotope, 2019-2028 (US$ Million)
13.5.5 South & Central America: Radiopharmaceutical Theranostics Market, by Source, 2019-2028 (US$ Million)
13.5.6 South & Central America: Radiopharmaceutical Theranostics Market, by Application, 2019-2028 (US$ Million)
13.5.7 South & Central America: Radiopharmaceutical Theranostics Market, by Indication, 2019-2028 (US$ Million)
13.5.8 South & Central America: Radiopharmaceutical Theranostics Market, by End User, 2019-2028 (US$ Million)
13.5.9 South & Central America: Radiopharmaceutical Theranostics Market, by Country, 2021 & 2028 (%)
13.5.9.1 Brazil: Radiopharmaceutical Theranostics Market - Revenue and Forecast to 2028 (US$ Million)
13.5.9.1.1 Overview
13.5.9.1.2 Brazil Radiopharmaceutical Theranostics Market - Revenue and Forecast to 2028 (US$ Million)
13.5.9.1.3 Brazil Radiopharmaceutical Theranostics Market, by Product type, 2019-2028 (US$ Million)
13.5.9.1.4 Brazil Radiopharmaceutical Theranostics Market, by Radioisotope, 2019-2028 (US$ Million)
13.5.9.1.5 Brazil Radiopharmaceutical Theranostics Market, by Source, 2019-2028 (US$ Million)
13.5.9.1.6 Brazil Radiopharmaceutical Theranostics Market, by Application, 2019-2028 (US$ Million)
13.5.9.1.7 Brazil Radiopharmaceutical Theranostics Market, by Indication, 2019-2028 (US$ Million)
13.5.9.1.8 Brazil Radiopharmaceutical Theranostics Market, by End User, 2019-2028 (US$ Million)
13.5.9.2 Argentina: Radiopharmaceutical Theranostics Market - Revenue and Forecast to 2028 (US$ Million)
13.5.9.2.1 Overview
13.5.9.2.2 Argentina Radiopharmaceutical Theranostics Market - Revenue and Forecast to 2028 (US$ Million)
13.5.9.2.3 Argentina Radiopharmaceutical Theranostics Market, by Product Type, 2019-2028 (US$ Million)
13.5.9.2.4 Argentina Radiopharmaceutical Theranostics Market, by Radioisotope, 2019-2028 (US$ Million)
13.5.9.2.5 Argentina Radiopharmaceutical Theranostics Market, by Source, 2019-2028 (US$ Million)
13.5.9.2.6 Argentina Radiopharmaceutical Theranostics Market, by Application, 2019-2028 (US$ Million)
13.5.9.2.7 Argentina Radiopharmaceutical Theranostics Market, by Indication, 2019-2028 (US$ Million)
13.5.9.2.8 Argentina Radiopharmaceutical Theranostics Market, by End User, 2019-2028 (US$ Million)
13.5.9.3 Rest of South & Central America: Radiopharmaceutical Theranostics Market - Revenue and Forecast to 2028 (US$ Million)
13.5.9.3.1 Overview
13.5.9.3.2 Rest of South & Central America Radiopharmaceutical Theranostics Market - Revenue and Forecast to 2028 (US$ Million)
13.5.9.3.3 Rest of South & Central America Radiopharmaceutical Theranostics Market, by Product Type, 2019-2028 (US$ Million)
13.5.9.3.4 Rest of South & Central America Radiopharmaceutical Theranostics Market, by Radioisotope, 2019-2028 (US$ Million)
13.5.9.3.5 Rest of South & Central America Radiopharmaceutical Theranostics Market, by Source, 2019-2028 (US$ Million)
13.5.9.3.6 Rest of South & Central America Radiopharmaceutical Theranostics Market, by Application, 2019-2028 (US$ Million)
13.5.9.3.7 Rest of South & Central America Radiopharmaceutical Theranostics Market, by Indication, 2019-2028 (US$ Million)
13.5.9.3.8 Rest of South & Central America Radiopharmaceutical Theranostics Market, by End User, 2019-2028 (US$ Million)
14. Impact Of COVID-19 Pandemic on Radiopharmaceutical Theranostics Market
14.1 North America: Impact Assessment of COVID-19 Pandemic
14.2 Europe: Impact Assessment of COVID-19 Pandemic
14.3 Asia Pacific: Impact Assessment of COVID-19 Pandemic
14.4 Middle East & Africa: Impact Assessment of COVID-19 Pandemic
14.5 South & Central America: Impact Assessment of COVID-19 Pandemic
15. Radiopharmaceutical Theranostics Market - Industry Landscape
15.1 Overview
15.2 Growth Strategies in the Radiopharmaceutical Theranostics Market
15.3 Inorganic Growth Strategies
15.3.1 Overview
15.4 Organic Growth Strategies
15.4.1 Overview
16. Company Profiles
16.1 Bayer AG
16.1.1 Key Facts
16.1.2 Business Description
16.1.3 Products and Services
16.1.4 Financial Overview
16.1.5 SWOT Analysis
16.1.6 Key Developments
16.2 GE HealthCare Technologies Inc
16.2.1 Key Facts
16.2.2 Business Description
16.2.3 Products and Services
16.2.4 Financial Overview
16.2.5 SWOT Analysis
16.2.6 Key Developments
16.3 Curium
16.3.1 Key Facts
16.3.2 Business Description
16.3.3 Products and Services
16.3.4 Financial Overview
16.3.5 SWOT Analysis
16.3.6 Key Developments
16.4 Lantheus Medical Imaging, Inc.
16.4.1 Key Facts
16.4.2 Business Description
16.4.3 Products and Services
16.4.4 Financial Overview
16.4.5 SWOT Analysis
16.4.6 Key Developments
16.5 Telix Pharmaceuticals Ltd.
16.5.1 Key Facts
16.5.2 Business Description
16.5.3 Products and Services
16.5.4 Financial Overview
16.5.5 SWOT Analysis
16.5.6 Key Developments
16.6 Cardinal Health Inc
16.6.1 Key Facts
16.6.2 Business Description
16.6.3 Products and Services
16.6.4 Financial Overview
16.6.5 SWOT Analysis
16.6.6 Key Developments
16.7 Advanced Accelerator Applications S.A.
16.7.1 Key Facts
16.7.2 Business Description
16.7.3 Products and Services
16.7.4 Financial Overview
16.7.5 SWOT Analysis
16.7.6 Key Developments
16.8 Jubilant Radiopharma
16.8.1 Key Facts
16.8.2 Business Description
16.8.3 Products and Services
16.8.4 Financial Overview
16.8.5 SWOT Analysis
16.8.6 Key Developments
16.9 Theragnostics
16.9.1 Key Facts
16.9.2 Business Description
16.9.3 Products a
List of Tables
Table 1. North America Radiopharmaceutical Theranostics Market, by Product Type - Revenue and Forecast to 2028 (US$ Million)
Table 2. North America Radiopharmaceutical Theranostics Market, by Radioisotope - Revenue and Forecast to 2028 (US$ Million)
Table 3. North America Radiopharmaceutical Theranostics Market, by Source - Revenue and Forecast to 2028 (US$ Million)
Table 4. North America Radiopharmaceutical Theranostics Market, by Application - Revenue and Forecast to 2028 (US$ Million)
Table 5. North America Radiopharmaceutical Theranostics Market, by Indication - Revenue and Forecast to 2028 (US$ Million)
Table 6. North America Radiopharmaceutical Theranostics Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 7. United States Radiopharmaceutical Theranostics Market, by Product Type - Revenue and Forecast to 2028 (US$ Million)
Table 8. United States Radiopharmaceutical Theranostics Market, by Radioisotope - Revenue and Forecast to 2028 (US$ Million)
Table 9. United States Radiopharmaceutical Theranostics Market, by Source - Revenue and Forecast to 2028 (US$ Million)
Table 10. United States Radiopharmaceutical Theranostics Market, by Application - Revenue and Forecast to 2028 (US$ Million)
Table 11. United States Radiopharmaceutical Theranostics Market, by Indication - Revenue and Forecast to 2028 (US$ Million)
Table 12. United States Radiopharmaceutical Theranostics Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 13. Canada Radiopharmaceutical Theranostics Market, by Product Type - Revenue and Forecast to 2028 (US$ Million)
Table 14. Canada Radiopharmaceutical Theranostics Market, by Radioisotope - Revenue and Forecast to 2028 (US$ Million)
Table 15. Canada Radiopharmaceutical Theranostics Market, by Source - Revenue and Forecast to 2028 (US$ Million)
Table 16. Canada Radiopharmaceutical Theranostics Market, by Application - Revenue and Forecast to 2028 (US$ Million)
Table 17. Canada Radiopharmaceutical Theranostics Market, by Indication - Revenue and Forecast to 2028 (US$ Million)
Table 18. Canada Radiopharmaceutical Theranostics Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 19. Mexico Radiopharmaceutical Theranostics Market, by Product Type - Revenue and Forecast to 2028 (US$ Million)
Table 20. Mexico Radiopharmaceutical Theranostics Market, by Radioisotope - Revenue and Forecast to 2028 (US$ Million)
Table 21. Mexico Radiopharmaceutical Theranostics Market, by Source - Revenue and Forecast to 2028 (US$ Million)
Table 22. Mexico Radiopharmaceutical Theranostics Market, by Application - Revenue and Forecast to 2028 (US$ Million)
Table 23. Mexico Radiopharmaceutical Theranostics Market, by Indication - Revenue and Forecast to 2028 (US$ Million)
Table 24. Mexico Radiopharmaceutical Theranostics Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 25. Europe Radiopharmaceutical Theranostics Market, by Product Type - Revenue and Forecast to 2028 (US$ Million)
Table 26. Europe Radiopharmaceutical Theranostics Market, by Radioisotope - Revenue and Forecast to 2028 (US$ Million)
Table 27. Europe Radiopharmaceutical Theranostics Market, by Source - Revenue and Forecast to 2028 (US$ Million)
Table 28. Europe Radiopharmaceutical Theranostics Market, by Application - Revenue and Forecast to 2028 (US$ Million)
Table 29. Europe Radiopharmaceutical Theranostics Market, by Indication - Revenue and Forecast to 2028 (US$ Million)
Table 30. Europe Radiopharmaceutical Theranostics Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 31. Germany Radiopharmaceutical Theranostics Market, by Product Type - Revenue and Forecast to 2028 (US$ Million)
Table 32. Germany Radiopharmaceutical Theranostics Market, by Radioisotope - Revenue and Forecast to 2028 (US$ Million)
Table 33. Germany Radiopharmaceutical Theranostics Market, by Source - Revenue and Forecast to 2028 (US$ Million)
Table 34. Germany Radiopharmaceutical Theranostics Market, by Application - Revenue and Forecast to 2028 (US$ Million)
Table 35. Germany Radiopharmaceutical Theranostics Market, by Indication - Revenue and Forecast to 2028 (US$ Million)
Table 36. Germany Radiopharmaceutical Theranostics Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 37. United Kingdom Radiopharmaceutical Theranostics Market, by Product type - Revenue and Forecast to 2028 (US$ Million)
Table 38. United Kingdom Radiopharmaceutical Theranostics Market, by Radioisotope - Revenue and Forecast to 2028 (US$ Million)
Table 39. United Kingdom Radiopharmaceutical Theranostics Market, by Source - Revenue and Forecast to 2028 (US$ Million)
Table 40. United Kingdom Radiopharmaceutical Theranostics Market, by Application - Revenue and Forecast to 2028 (US$ Million)
Table 41. United Kingdom Radiopharmaceutical Theranostics Market, by Indication - Revenue and Forecast to 2028 (US$ Million)
Table 42. United Kingdom Radiopharmaceutical Theranostics Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 43. France Radiopharmaceutical Theranostics Market, by Product Type - Revenue and Forecast to 2028 (US$ Million)
Table 44. France Radiopharmaceutical Theranostics Market, by Radioisotope - Revenue and Forecast to 2028 (US$ Million)
Table 45. France Radiopharmaceutical Theranostics Market, by Source - Revenue and Forecast to 2028 (US$ Million)
Table 46. France Radiopharmaceutical Theranostics Market, by Application - Revenue and Forecast to 2028 (US$ Million)
Table 47. France Radiopharmaceutical Theranostics Market, by Indication - Revenue and Forecast to 2028 (US$ Million)
Table 48. France Radiopharmaceutical Theranostics Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 49. Italy Radiopharmaceutical Theranostics Market, by Product Type - Revenue and Forecast to 2028 (US$ Million)
Table 50. Italy Radiopharmaceutical Theranostics Market, by Radioisotope - Revenue and Forecast to 2028 (US$ Million)
Table 51. Italy Radiopharmaceutical Theranostics Market, by Source - Revenue and Forecast to 2028 (US$ Million)
Table 52. Italy Radiopharmaceutical Theranostics Market, by Application - Revenue and Forecast to 2028 (US$ Million)
Table 53. Italy Radiopharmaceutical Theranostics Market, by Indication - Revenue and Forecast to 2028 (US$ Million)
Table 54. Italy Radiopharmaceutical Theranostics Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 55. Spain Radiopharmaceutical Theranostics Market, by Product Type - Revenue and Forecast to 2028 (US$ Million)
Table 56. Spain Radiopharmaceutical Theranostics Market, by Radioisotope - Revenue and Forecast to 2028 (US$ Million)
Table 57. Spain Radiopharmaceutical Theranostics Market, by Source - Revenue and Forecast to 2028 (US$ Million)
Table 58. Spain Radiopharmaceutical Theranostics Market, by Application - Revenue and Forecast to 2028 (US$ Million)
Table 59. Spain Radiopharmaceutical Theranostics Market, by Indication - Revenue and Forecast to 2028 (US$ Million)
Table 60. Spain Radiopharmaceutical Theranostics Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 61. Rest of Europe Radiopharmaceutical Theranostics Market, by Product Type - Revenue and Forecast to 2028 (US$ Million)
Table 62. Rest of Europe Radiopharmaceutical Theranostics Market, by Radioisotope - Revenue and Forecast to 2028 (US$ Million)
Table 63. Rest of Europe Radiopharmaceutical Theranostics Market, by Source - Revenue and Forecast to 2028 (US$ Million)
Table 64. Rest of Europe Radiopharmaceutical Theranostics Market, by Application - Revenue and Forecast to 2028 (US$ Million)
Table 65. Rest of Europe Radiopharmaceutical Theranostics Market, by Indication - Revenue and Forecast to 2028 (US$ Million)
Table 66. Rest of Europe Radiopharmaceutical Theranostics Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 67. Asia Pacific Radiopharmaceutical Theranostics Market, by Product Type - Revenue and Forecast to 2028 (US$ Million)
Table 68. Asia Pacific Radiopharmaceutical Theranostics Market, by Radioisotope - Revenue and Forecast to 2028 (US$ Million)
Table 69. Asia Pacific Radiopharmaceutical Theranostics Market, by Source - Revenue and Forecast to 2028 (US$ Million)
Table 70. Asia Pacific Radiopharmaceutical Theranostics Market, by Application - Revenue and Forecast to 2028 (US$ Million)
Table 71. Asia Pacific Radiopharmaceutical Theranostics Market, by Indication - Revenue and Forecast to 2028 (US$ Million)
Table 72. Asia Pacific Radiopharmaceutical Theranostics Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 73. China Radiopharmaceutical Theranostics Market, by Product Type - Revenue and Forecast to 2028 (US$ Million)
Table 74. China Radiopharmaceutical Theranostics Market, by Radioisotope - Revenue and Forecast to 2028 (US$ Million)
Table 75. China Radiopharmaceutical Theranostics Market, by Source - Revenue and Forecast to 2028 (US$ Million)
Table 76. China Radiopharmaceutical Theranostics Market, by Application - Revenue and Forecast to 2028 (US$ Million)
Table 77. China Radiopharmaceutical Theranostics Market, by Indication - Revenue and Forecast to 2028 (US$ Million)
Table 78. China Radiopharmaceutical Theranostics Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 79. Japan Radiopharmaceutical Theranostics Market, by Product Type - Revenue and Forecast to 2028 (US$ Million)
Table 80. Japan Radiopharmaceutical Theranostics Market, by Radioisotope - Revenue and Forecast to 2028 (US$ Million)
Table 81. Japan Radiopharmaceutical Theranostics Market, by Source - Revenue and Forecast to 2028 (US$ Million)
Table 82. Japan Radiopharmaceutical Theranostics Market, by Application - Revenue and Forecast to 2028 (US$ Million)
Table 83. Japan Radiopharmaceutical Theranostics Market, by Indication - Revenue and Forecast to 2028 (US$ Million)
Table 84. Japan Radiopharmaceutical Theranostics Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 85. India Radiopharmaceutical Theranostics Market, by Product Type - Revenue and Forecast to 2028 (US$ Million)
Table 86. India Radiopharmaceutical Theranostics Market, by Radioisotope - Revenue and Forecast to 2028 (US$ Million)
Table 87. India Radiopharmaceutical Theranostics Market, by Source - Revenue and Forecast to 2028 (US$ Million)
Table 88. India Radiopharmaceutical Theranostics Market, by Application - Revenue and Forecast to 2028 (US$ Million)
Table 89. India Radiopharmaceutical Theranostics Market, by Indication - Revenue and Forecast to 2028 (US$ Million)
Table 90. India Radiopharmaceutical Theranostics Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 91. South Korea Radiopharmaceutical Theranostics Market, by Product Type - Revenue and Forecast to 2028 (US$ Million)
Table 92. South Korea Radiopharmaceutical Theranostics Market, by Radioisotope - Revenue and Forecast to 2028 (US$ Million)
Table 93. South Korea Radiopharmaceutical Theranostics Market, by Source - Revenue and Forecast to 2028 (US$ Million)
Table 94. South Korea Radiopharmaceutical Theranostics Market, by Application - Revenue and Forecast to 2028 (US$ Million)
Table 95. South Korea Radiopharmaceutical Theranostics Market, by Indication - Revenue and Forecast to 2028 (US$ Million)
Table 96. South Korea Radiopharmaceutical Theranostics Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 97. Australia Radiopharmaceutical Theranostics Market, by Product Type - Revenue and Forecast to 2028 (US$ Million)
Table 98. Australia Radiopharmaceutical Theranostics Market, by Radioisotope - Revenue and Forecast to 2028 (US$ Million)
Table 99. Australia Radiopharmaceutical Theranostics Market, by Source - Revenue and Forecast to 2028 (US$ Million)
Table 100. Australia Radiopharmaceutical Theranostics Market, by Application - Revenue and Forecast to 2028 (US$ Million)
Table 101. Australia Radiopharmaceutical Theranostics Market, by Indication - Revenue and Forecast to 2028 (US$ Million)
Table 102. Australia Radiopharmaceutical Theranostics Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 103. Rest of Asia Pacific Radiopharmaceutical Theranostics Market, by Product Type - Revenue and Forecast to 2028 (US$ Million)
Table 104. Rest of Asia Pacific Radiopharmaceutical Theranostics Market, by Radioisotope - Revenue and Forecast to 2028 (US$ Million)
Table 105. Rest of Asia Pacific Radiopharmaceutical Theranostics Market, by Source - Revenue and Forecast to 2028 (US$ Million)
Table 106. Rest of Asia Pacific Radiopharmaceutical Theranostics Market, by Application - Revenue and Forecast to 2028 (US$ Million)
Table 107. Rest of Asia Pacific Radiopharmaceutical Theranostics Market, by Indication - Revenue and Forecast to 2028 (US$ Million)
Table 108. Rest of Asia Pacific Radiopharmaceutical Theranostics Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 109. Middle East & Africa Radiopharmaceutical Theranostics Market, by Product Type - Revenue and Forecast to 2028 (US$ Million)
Table 110. Middle East & Africa Radiopharmaceutical Theranostics Market, by Radioisotope - Revenue and Forecast to 2028 (US$ Million)
Table 111. Middle East & Africa Radiopharmaceutical Theranostics Market, by Source - Revenue and Forecast to 2028 (US$ Million)
Table 112. Middle East & Africa Radiopharmaceutical Theranostics Market, by Application - Revenue and Forecast to 2028 (US$ Million)
Table 113. Middle East & Africa Radiopharmaceutical Theranostics Market, by Indication - Revenue and Forecast to 2028 (US$ Million)
Table 114. Middle East & Africa Radiopharmaceutical Theranostics Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 115. Saudi Arabia Radiopharmaceutical Theranostics Market, by Product Type - Revenue and Forecast to 2028 (US$ Million)
Table 116. Saudi Arabia Radiopharmaceutical Theranostics Market, by Radioisotope - Revenue and Forecast to 2028 (US$ Million)
Table 117. Saudi Arabia Radiopharmaceutical Theranostics Market, by Source - Revenue and Forecast to 2028 (US$ Million)
Table 118. Saudi Arabia Radiopharmaceutical Theranostics Market, by Application - Revenue and Forecast to 2028 (US$ Million)
Table 119. Saudi Arabia Radiopharmaceutical Theranostics Market, by Indication - Revenue and Forecast to 2028 (US$ Million)
Table 120. Saudi Arabia Radiopharmaceutical Theranostics Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 121. South Africa Radiopharmaceutical Theranostics Market, by Product type - Revenue and Forecast to 2028 (US$ Million)
Table 122. South Africa Radiopharmaceutical Theranostics Market, by Radioisotope - Revenue and Forecast to 2028 (US$ Million)
Table 123. South Africa Radiopharmaceutical Theranostics Market, by Source - Revenue and Forecast to 2028 (US$ Million)
Table 124. South Africa Radiopharmaceutical Theranostics Market, by Application - Revenue and Forecast to 2028 (US$ Million)
Table 125. South Africa Radiopharmaceutical Theranostics Market, by Indication - Revenue and Forecast to 2028 (US$ Million)
Table 126. South Africa Radiopharmaceutical Theranostics Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 127. UAE Radiopharmaceutical Theranostics Market, by Product Type - Revenue and Forecast to 2028 (US$ Million)
Table 128. UAE Radiopharmaceutical Theranostics Market, by Radioisotope - Revenue and Forecast to 2028 (US$ Million)
Table 129. UAE Radiopharmaceutical Theranostics Market, by Source - Revenue and Forecast to 2028 (US$ Million)
Table 130. UAE Radiopharmaceutical Theranostics Market, by Application - Revenue and Forecast to 2028 (US$ Million)
Table 131. UAE Radiopharmaceutical Theranostics Market, by Indication - Revenue and Forecast to 2028 (US$ Million)
Table 132. UAE Radiopharmaceutical Theranostics Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 133. Rest of Middle East & Africa Radiopharmaceutical Theranostics Market, by Product Type - Revenue and Forecast to 2028 (US$ Million)
Table 134. Rest of Middle East & Africa Radiopharmaceutical Theranostics Market, by Radioisotope - Revenue and Forecast to 2028 (US$ Million)
Table 135. Rest of Middle East & Africa Radiopharmaceutical Theranostics Market, by Source - Revenue and Forecast to 2028 (US$ Million)
Table 136. Rest of Middle East & Africa Radiopharmaceutical Theranostics Market, by Application - Revenue and Forecast to 2028 (US$ Million)
Table 137. Rest of Middle East & Africa Radiopharmaceutical Theranostics Market, by Indication - Revenue and Forecast to 2028 (US$ Million)
Table 138. Rest of Middle East & Africa Radiopharmaceutical Theranostics Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 139. South & Central America Radiopharmaceutical Theranostics Market, by Product Type - Revenue and Forecast to 2028 (US$ Million)
Table 140. South & Central America Radiopharmaceutical Theranostics Market, by Radioisotope - Revenue and Forecast to 2028 (US$ Million)
Table 141. South & Central America Radiopharmaceutical Theranostics Market, by Source - Revenue and Forecast to 2028 (US$ Million)
Table 142. South & Central America Radiopharmaceutical Theranostics Market, by Application - Revenue and Forecast to 2028 (US$ Million)
Table 143. South & Central America Radiopharmaceutical Theranostics Market, by Indication - Revenue and Forecast to 2028 (US$ Million)
Table 144. South & Central America Radiopharmaceutical Theranostics Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 145. Brazil Radiopharmaceutical Theranostics Market, by Product type - Revenue and Forecast to 2028 (US$ Million)
Table 146. Brazil Radiopharmaceutical Theranostics Market, by Radioisotope - Revenue and Forecast to 2028 (US$ Million)
Table 147. Brazil Radiopharmaceutical Theranostics Market, by Source - Revenue and Forecast to 2028 (US$ Million)
Table 148. Brazil Radiopharmaceutical Theranostics Market, by Application - Revenue and Forecast to 2028 (US$ Million)
Table 149. Brazil Radiopharmaceutical Theranostics Market, by Indication - Revenue and Forecast to 2028 (US$ Million)
Table 150. Brazil Radiopharmaceutical Theranostics Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 151. Argentina Radiopharmaceutical Theranostics Market, by Product Type - Revenue and Forecast to 2028 (US$ Million)
Table 152. Argentina Radiopharmaceutical Theranostics Market, by Radioisotope - Revenue and Forecast to 2028 (US$ Million)
Table 153. Argentina Radiopharmaceutical Theranostics Market, by Source - Revenue and Forecast to 2028 (US$ Million)
Table 154. Argentina Radiopharmaceutical Theranostics Market, by Application - Revenue and Forecast to 2028 (US$ Million)
Table 155. Argentina Radiopharmaceutical Theranostics Market, by Indication - Revenue and Forecast to 2028 (US$ Million)
Table 156. Argentina Radiopharmaceutical Theranostics Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 157. Rest of South & Central America Radiopharmaceutical Theranostics Market, by Product Type - Revenue and Forecast to 2028 (US$ Million)
Table 158. Rest of South & Central America Radiopharmaceutical Theranostics Market, by Radioisotope - Revenue and Forecast to 2028 (US$ Million)
Table 159. Rest of South & Central America Radiopharmaceutical Theranostics Market, by Source - Revenue and Forecast to 2028 (US$ Million)
Table 160. Rest of South & Central America Radiopharmaceutical Theranostics Market, by Application - Revenue and Forecast to 2028 (US$ Million)
Table 161. Rest of South & Central America Radiopharmaceutical Theranostics Market, by Indication - Revenue and Forecast to 2028 (US$ Million)
Table 162. Rest of South & Central America Radiopharmaceutical Theranostics Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 163. Recent Inorganic Growth Strategies in the Radiopharmaceutical Theranostics Market
Table 164. Recent Organic Growth Strategies in the Radiopharmaceutical Theranostics Market
Table 165. Glossary of Terms
List of Figures
Figure 1 Radiopharmaceutical Theranostics Market Segmentation
Figure 2. Radiopharmaceutical Theranostics Market, by Region
Figure 3. Global Radiopharmaceutical Theranostics Market Overview
Figure 4. Positron Emission Tomography (PET) Tracers Segment Held Largest Share of Product Type Segment in Radiopharmaceutical Theranostics Market
Figure 5. Asia Pacific Expected to Show Remarkable Growth During Forecast Period
Figure 6. Radiopharmaceutical Theranostics Market, by Geography (US$ Million)
Figure 7. Global Radiopharmaceutical Theranostics Market - Leading Country Markets (US$ Million)
Figure 8. Global Radiopharmaceutical Theranostics Market - Industry Landscape
Figure 9. North America: PEST Analysis
Figure 10. Europe: PEST Analysis
Figure 11. Asia Pacific: PEST Analysis
Figure 12. South & Central America: PEST Analysis
Figure 13. Middle East & Africa: PEST Analysis
Figure 14. Experts’ Opinion
Figure 15. Radiopharmaceutical Theranostics Market: Impact Analysis of Drivers and Restraints
Figure 16. Global Radiopharmaceutical Theranostics Market - Revenue Forecast and Analysis - 2020-2028
Figure 17. Global Radiopharmaceutical Theranostics Market, by Geography - Forecast and Analysis (2021-2028)
Figure 18. Market Positioning of Key Players in Radiopharmaceutical Theranostics Market
Figure 19. Global Radiopharmaceutical Theranostics Market Revenue Share, by Product Type 2021 & 2028 (%)
Figure 20. Positron Emission Tomography (PET) Tracers: Global Radiopharmaceutical Theranostics Market - Revenue and Forecast to 2028 (US$ Million)
Figure 21. Beta Emitters: Global Radiopharmaceutical Theranostics Market - Revenue and Forecast to 2028 (US$ Million)
Figure 22. Alpha Emitters: Global Radiopharmaceutical Theranostics Market - Revenue and Forecast to 2028 (US$ Million)
Figure 23. Global Radiopharmaceutical Theranostics Market, by Radioisotope, 2021 & 2028 (%)
Figure 24. Technetium-99: Global Radiopharmaceutical Theranostics Market - Revenue and Forecast to 2028 (US$ Million)
Figure 25. Gallium-68: Global Radiopharmaceutical Theranostics Market - Revenue and Forecast to 2028 (US$ Million)
Figure 26. Iodine-131: Global Radiopharmaceutical Theranostics Market - Revenue and Forecast to 2028 (US$ Million)
Figure 27. Iodine-123: Global Radiopharmaceutical Theranostics Market - Revenue and Forecast to 2028 (US$ Million)
Figure 28. Fluorine-18 (18F): Global Radiopharmaceutical Theranostics Market - Revenue and Forecast to 2028 (US$ Million)
Figure 29. Yttrium 90 (Y-90): Global Radiopharmaceutical Theranostics Market - Revenue and Forecast to 2028 (US$ Million)
Figure 30. Lutetium (LU) 177: Global Radiopharmaceutical Theranostics Market - Revenue and Forecast to 2028 (US$ Million)
Figure 31. Copper (CU) 67: Global Radiopharmaceutical Theranostics Market - Revenue and Forecast to 2028 (US$ Million)
Figure 32. Copper (CU) 64: Global Radiopharmaceutical Theranostics Market - Revenue and Forecast to 2028 (US$ Million)
Figure 33. Others: Global Radiopharmaceutical Theranostics Market - Revenue and Forecast to 2028 (US$ Million)
Figure 34. Global Radiopharmaceutical Theranostics Market, by Source, 2021 & 2028 (%)
Figure 35. Nuclear Reactors: Global Radiopharmaceutical Theranostics Market - Revenue and Forecast to 2028 (US$ Million)
Figure 36. Cyclotrons: Global Radiopharmaceutical Theranostics Market - Revenue and Forecast to 2028 (US$ Million)
Figure 37. Global Radiopharmaceutical Theranostics Market, by Application, 2021 & 2028 (%)
Figure 38. Targeted Therapeutics (Rx): Global Radiopharmaceutical Theranostics Market - Revenue and Forecast to 2028 (US$ Million)
Figure 39. Companion Diagnostics (CDx): Global Radiopharmaceutical Theranostics Market - Revenue and Forecast to 2028 (US$ Million)
Figure 40. Global Radiopharmaceutical Theranostics Market, by Indication, 2021 & 2028 (%)
Figure 41. Oncology: Global Radiopharmaceutical Theranostics Market - Revenue and Forecast to 2028 (US$ Million)
Figure 42. Neurology: Global Radiopharmaceutical Theranostics Market - Revenue and Forecast to 2028 (US$ Million)
Figure 43. Cardiology: Global Radiopharmaceutical Theranostics Market - Revenue and Forecast to 2028 (US$ Million)
Figure 44. Others: Global Radiopharmaceutical Theranostics Market - Revenue and Forecast to 2028 (US$ Million)
Figure 45. Global Radiopharmaceutical Theranostics Market, by End User, 2021 & 2028 (%)
Figure 46. Hospitals: Global Radiopharmaceutical Theranostics Market - Revenue and Forecast to 2028 (US$ Million)
Figure 47. Diagnostic Imaging Centers: Global Radiopharmaceutical Theranostics Market - Revenue and Forecast to 2028 (US$ Million)
Figure 48. Academic & Research Institutes: Global Radiopharmaceutical Theranostics Market - Revenue and Forecast to 2028 (US$ Million)
Figure 49. Others: Global Radiopharmaceutical Theranostics Market - Revenue and Forecast to 2028 (US$ Million)
Figure 50. North America: Radiopharmaceutical Theranostics Market, by Key Country - Revenue (2021) (US$ Million)
Figure 51. North America Radiopharmaceutical Theranostics Market - Revenue and Forecast to 2028 (US$ Million)
Figure 52. North America: Radiopharmaceutical Theranostics Market, by Country, 2021 & 2028 (%)
Figure 53. United States: Radiopharmaceutical Theranostics Market - Revenue and Forecast to 2028 (US$ Million)
Figure 54. Canada: Radiopharmaceutical Theranostics Market - Revenue and Forecast to 2028 (US$ Million)
Figure 55. Mexico: Radiopharmaceutical Theranostics Market - Revenue and Forecast to 2028 (US$ Million)
Figure 56. Europe: Radiopharmaceutical Theranostics Market, by Key Country - Revenue (2021) (US$ Million)
Figure 57. Europe Radiopharmaceutical Theranostics Market - Revenue and Forecast to 2028 (US$ Million)
Figure 58. Europe: Radiopharmaceutical Theranostics Market, by Country, 2021 & 2028 (%)
Figure 59. Germany Radiopharmaceutical Theranostics Market - Revenue and Forecast to 2028 (US$ Million)
Figure 60. United Kingdom Radiopharmaceutical Theranostics Market - Revenue and Forecast to 2028 (US$ Million)
Figure 61. France Radiopharmaceutical Theranostics Market - Revenue and Forecast to 2028 (US$ Million)
Figure 62. Italy Radiopharmaceutical Theranostics Market - Revenue and Forecast to 2028 (US$ Million)
Figure 63. Spain Radiopharmaceutical Theranostics Market - Revenue and Forecast to 2028 (US$ Million)
Figure 64. Rest of Europe Radiopharmaceutical Theranostics Market - Revenue and Forecast to 2028 (US$ Million)
Figure 65. Asia Pacific: Radiopharmaceutical Theranostics Market, by Key Country - Revenue (2021) (US$ Million)
Figure 66. Asia Pacific Radiopharmaceutical Theranostics Market - Revenue and Forecast to 2028 (US$ Million)
Figure 67. China: Radiopharmaceutical Theranostics Market - Revenue and Forecast to 2028 (US$ Million)
Figure 68. Japan: Radiopharmaceutical Theranostics Market - Revenue and Forecast to 2028 (US$ Million)
Figure 69. India: Radiopharmaceutical Theranostics Market - Revenue and Forecast to 2028 (US$ Million)
Figure 70. South Korea: Radiopharmaceutical Theranostics Market - Revenue and Forecast to 2028 (US$ Million)
Figure 71. Australia: Radiopharmaceutical Theranostics Market - Revenue and Forecast to 2028 (US$ Million)
Figure 72. Rest of Asia Pacific: Radiopharmaceutical Theranostics Market - Revenue and Forecast to 2028 (US$ Million)
Figure 73. Middle East & Africa: Radiopharmaceutical Theranostics Market, by Key Country - Revenue (2021) (US$ Million)
Figure 74. Middle East & Africa Radiopharmaceutical Theranostics Market - Revenue and Forecast to 2028 (US$ Million)
Figure 75. Saudi Arabia Radiopharmaceutical Theranostics Market - Revenue and Forecast to 2028 (US$ Million)
Figure 76. South Africa Radiopharmaceutical Theranostics Market - Revenue and Forecast to 2028 (US$ Million)
Figure 77. UAE Radiopharmaceutical Theranostics Market - Revenue and Forecast to 2028 (US$ Million)
Figure 78. Rest of Middle East & Africa Radiopharmaceutical Theranostics Market - Revenue and Forecast to 2028 (US$ Million)
Figure 79. South & Central America: Radiopharmaceutical Theranostics Market, by Key Country - Revenue (2021) (US$ Million)
Figure 80. South & Central America Radiopharmaceutical Theranostics Market - Revenue and Forecast to 2028 (US$ Million)
Figure 81. South & Central America: Radiopharmaceutical Theranostics Market, by Country, 2021 & 2028 (%)
Figure 82. Brazil Radiopharmaceutical Theranostics Market - Revenue and Forecast to 2028 (US$ Million)
Figure 83. Argentina Radiopharmaceutical Theranostics Market - Revenue and Forecast to 2028 (US$ Million)
Figure 84. Rest of South & Central America Radiopharmaceutical Theranostics Market - Revenue and Forecast to 2028 (US$ Million)
Figure 85. Impact of COVID-19 Pandemic on North American Country Markets
Figure 86. Impact of COVID-19 Pandemic in European Country Markets
Figure 87. Impact of COVID-19 Pandemic in Asia Pacific Country Markets
Figure 88. Impact of COVID-19 Pandemic in Middle East & Africa Country Markets
Figure 89. Impact of COVID-19 Pandemic on South & Central American Country Markets
Figure 90. Growth Strategies in the Radiopharmaceutical Theranostics Market

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Bayer AG
  • GE HealthCare Technologies Inc
  • Curium
  • Lantheus Medical Imaging, Inc.
  • Telix Pharmaceuticals Ltd.
  • Cardinal Health Inc
  • Advanced Accelerator Applications S.A.
  • Jubilant Radiopharma
  • Theragnostics
  • NuView Life Sciences

Table Information

Report AttributeDetails
No. of Pages185
PublishedMarch 2023
Forecast Period2022 - 2028
Estimated Market Value ( USD ) in 2022 $ 1814.58 million
Forecasted Market Value ( USD ) by 2028 $ 3441.97 million
Compound Annual Growth Rate11.3%
Regions CoveredGlobal

Related Topics

Related Reports

Radiopharmaceutical Theranostics Global Market Report 2024 - Product Image

Radiopharmaceutical Theranostics Global Market Report 2024

  • Report
  • 175 Pages
  • Global
From
Global Theranostics Market by Product (Diagnostic imaging (PET, CT, MRI), Radiopharmaceuticals (Lu-177, Sm-153, Ra-223, I-131), Biomarker screening, Software), Application (Prostate Cancer, Bone metastasis), & Stakeholder Expectations - Forecast to 2028 - Product Image

Global Theranostics Market by Product (Diagnostic imaging (PET, CT, MRI), Radiopharmaceuticals (Lu-177, Sm-153, Ra-223, I-131), Biomarker screening, Software), Application (Prostate Cancer, Bone metastasis), & Stakeholder Expectations - Forecast to 2028

  • Report
  • 194 Pages
  • Global
From
Global Radiopharmaceutical Theranostics Market Report and Forecast 2023-2031 - Product Image

Global Radiopharmaceutical Theranostics Market Report and Forecast 2023-2031

  • Report
  • 140 Pages
  • Global
From
Global Theranostics Market Size, Share & Trends Analysis Report By End User, By Product (Radiopharmaceuticals, Diagnostic Imaging, IVD/Biomarker Screening, and Software & Services), By Application, By Regional Outlook and Forecast, 2023 - 2030 - Product Image

Global Theranostics Market Size, Share & Trends Analysis Report By End User, By Product (Radiopharmaceuticals, Diagnostic Imaging, IVD/Biomarker Screening, and Software & Services), By Application, By Regional Outlook and Forecast, 2023 - 2030

  • Report
  • 239 Pages
  • Global
From
Radiopharmaceutical Theranostics Market Report: Trends, Forecast and Competitive Analysis to 2030 - Product Image

Radiopharmaceutical Theranostics Market Report: Trends, Forecast and Competitive Analysis to 2030

  • Report
  • 150 Pages
  • Global
From
Copyright © 2002-2024 Research and Markets. All Rights Reserved.